BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10945536)

  • 21. Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand.
    Ishiwata K; Noguchi J; Ishii S; Hatano K; Ito K; Nabeshima T; Senda M
    Nucl Med Biol; 1998 Apr; 25(3):195-202. PubMed ID: 9620623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography.
    Kawamura K; Akiyama M; Yui J; Yamasaki T; Hatori A; Kumata K; Wakizaka H; Takei M; Nengaki N; Yanamoto K; Fukumura T; Zhang MR
    ACS Chem Neurosci; 2010 Jul; 1(7):520-8. PubMed ID: 22778842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain.
    Zhang MR; Kumata K; Maeda J; Yanamoto K; Hatori A; Okada M; Higuchi M; Obayashi S; Suhara T; Suzuki K
    J Nucl Med; 2007 Nov; 48(11):1853-61. PubMed ID: 17978354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase).
    Pomper MG; Musachio JL; Zhang J; Scheffel U; Zhou Y; Hilton J; Maini A; Dannals RF; Wong DF; Kozikowski AP
    Mol Imaging; 2002; 1(2):96-101. PubMed ID: 12920850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET.
    Suehiro M; Scheffel U; Ravert HT; Dannals RF; Wagner HN
    Life Sci; 1993; 53(11):883-92. PubMed ID: 8366755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [11C]SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats.
    Zessin J; Deuther-Conrad W; Kretzschmar M; Wüst F; Pawelke B; Brust P; Steinbach J; Bergmann R
    Nucl Med Biol; 2006 Jan; 33(1):53-63. PubMed ID: 16459259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
    Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
    Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
    J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors.
    Sekimata K; Hatano K; Ogawa M; Abe J; Magata Y; Biggio G; Serra M; Laquintana V; Denora N; Latrofa A; Trapani G; Liso G; Ito K
    Nucl Med Biol; 2008 Apr; 35(3):327-34. PubMed ID: 18355688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.
    Liow JS; Lu S; McCarron JA; Hong J; Musachio JL; Pike VW; Innis RB; Zoghbi SS
    Synapse; 2007 Feb; 61(2):96-105. PubMed ID: 17117422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
    Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
    Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
    Vasdev N; Natesan S; Galineau L; Garcia A; Stableford WT; McCormick P; Seeman P; Houle S; Wilson AA
    Synapse; 2006 Sep; 60(4):314-8. PubMed ID: 16786538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-[11C-Methyl]chlorphentermine and N,N-[11C-dimethyl]chlorphentermine as brain blood-flow agents for positron emission tomography.
    Kizuka H; Elmaleh DR; Boudreaux GJ; Strauss HW; Ackerman RH; Brownell GL
    J Nucl Med; 1986 Apr; 27(4):532-7. PubMed ID: 3486957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat.
    Luurtsema G; Molthoff CF; Schuit RC; Windhorst AD; Lammertsma AA; Franssen EJ
    Nucl Med Biol; 2005 Jan; 32(1):87-93. PubMed ID: 15691665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
    Ding YS; Lin KS; Logan J; Benveniste H; Carter P
    J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers.
    Zhang J; McCarthy TJ; Moore WM; Currie MG; Welch MJ
    J Med Chem; 1996 Dec; 39(26):5110-8. PubMed ID: 8978842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
    J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone.
    Bottlaender M; Dolle F; Guenther I; Roumenov D; Fuseau C; Bramoulle Y; Curet O; Jegham J; Pinquier JL; George P; Valette H
    J Pharmacol Exp Ther; 2003 May; 305(2):467-73. PubMed ID: 12606609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.
    Yanamoto K; Yamasaki T; Kumata K; Yui J; Odawara C; Kawamura K; Hatori A; Inoue O; Yamaguchi M; Suzuki K; Zhang MR
    Synapse; 2009 Nov; 63(11):961-71. PubMed ID: 19593823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.